Lina Alhaddad
Overview
Explore the profile of Lina Alhaddad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alhaddad L, Osipov A, Leonov S
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684218
Radiotherapy (RT) has been shown to be a cornerstone of both palliative and curative tumor care. RT has generally been reported to be sharply limited by ionizing radiation (IR)-induced toxicity,...
2.
Leonov S, Dorfman A, Pershikova E, Inyang O, Alhaddad L, Wang Y, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927940
During the cell life cycle, extracellular vesicles (EVs) transport different cargos, including organelles, proteins, RNAs, DNAs, metabolites, etc., that influence cell proliferation and apoptosis in recipient cells. EVs from metastatic...
3.
Meyer C, Alhaddad L, Stammel N, Sixtus F, Wesche J, Kerschreiter R, et al.
Front Psychiatry
. 2023 Apr;
14:1130199.
PMID: 37009112
Introduction: Refugee youth are often faced with the compounding challenges of heightened exposure to traumatic events and acculturating to a new country during a developmental period when their sense of...
4.
Alhaddad L, Nofal Z, Pustovalova M, Osipov A, Leonov S
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768320
The overall effect of senescence on cancer progression and cancer cell resistance to X-ray radiation (IR) is still not fully understood and remains controversial. How to induce tumor cell senescence...
5.
Alhaddad L, Chuprov-Netochin R, Pustovalova M, Osipov A, Leonov S
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674747
Radioresistance compromises the efficacy of radiotherapy for glioblastoma multiforme (GBM), the most devastating and common brain tumor. The present study investigated the relationship between radiation tolerance and formation of polyploid/multinucleated...
6.
Alhaddad L, Osipov A, Leonov S
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362359
Ionizing radiation (IR) has been shown to play a crucial role in the treatment of glioblastoma (GBM; grade IV) and non-small-cell lung cancer (NSCLC). Nevertheless, recent studies have indicated that...
7.
Pustovalova M, Blokhina T, Alhaddad L, Chigasova A, Chuprov-Netochin R, Veviorskiy A, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563313
Cancer stem cells (CSCs) play a critical role in the initiation, progression and therapy relapse of many cancers including non-small cell lung cancer (NSCLC). Here, we aimed to address the...
8.
Alhaddad L, Pustovalova M, Blokhina T, Chuprov-Netochin R, Osipov A, Leonov S
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34071477
Radiotherapy is a primary treatment modality for patients with unresectable non-small cell lung cancer (NSCLC). Tumor heterogeneity still poses the central question of cancer radioresistance, whether the presence of a...
9.
Pustovalova M, Alhaddad L, Blokhina T, Smetanina N, Chigasova A, Chuprov-Netochin R, et al.
Int J Mol Sci
. 2021 Mar;
22(5).
PMID: 33673439
Ionizing radiation (IR) is used for patients diagnosed with unresectable non-small cell lung cancer (NSCLC). However, radiotherapy remains largely palliative due to the survival of specific cell subpopulations. In the...
10.
Pustovalova M, Alhaddad L, Smetanina N, Chigasova A, Blokhina T, Chuprov-Netochin R, et al.
Int J Mol Sci
. 2020 May;
21(9).
PMID: 32397297
Radiation therapy is one of the main methods of treating patients with non-small cell lung cancer (NSCLC). However, the resistance of tumor cells to exposure remains the main factor that...